Drug Insight: statins for nonischemic heart failure—evidence and potential mechanisms
- 1 April 2007
- journal article
- research article
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 4 (4) , 196-205
- https://doi.org/10.1038/ncpcardio0855
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyBMJ, 2006
- Effect of Ezetimibe and/or Simvastatin on Coenzyme Q10 Levels in PlasmaDrug Safety, 2006
- Neutral Effect on Markers of Heart Failure, Inflammation, Endothelial Activation and Function, and Vagal Tone After High-Dose HMG-CoA Reductase Inhibition in Non-Diabetic Patients With Non-Ischemic Cardiomyopathy and Average Low-Density Lipoprotein LevelJournal of the American College of Cardiology, 2005
- Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic MechanismsNature Reviews Drug Discovery, 2005
- The Importance of Heart Rate Recovery in Patients With Heart Failure or Left Ventricular Systolic DysfunctionJournal of Cardiac Failure, 2005
- Short-Term Adjuvant Atorvastatin Improves Frequency Domain Indices of Heart Rate Variability in Stable Systolic Heart FailureCardiovascular Drugs and Therapy, 2005
- Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patientsAmerican Heart Journal, 2005
- Simvastatin Normalizes Autonomic Neural Control in Experimental Heart FailureCirculation, 2003
- Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.Journal of Clinical Pathology, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993